Provexis (PXS) Competitors GBX 0.71 -0.03 (-4.34%) As of 08/12/2025 06:29 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsBuy This Stock PXS vs. NSH, ALK, CLCO, ICON, PAA, GEL, MMP, CCL, AAL, and SAVEShould you be buying Provexis stock or one of its competitors? The main competitors of Provexis include Norish (NSH), Alkemy Capital Investments (ALK), CloudCoCo Group (CLCO), Iconic Labs (ICON), 22532 (PAA.L) (PAA), Greka Engineering & Technology (GEL), Marwyn Management Partners (MMP), Carnival Co. & (CCL), Anglo American (AAL), and Savannah Energy (SAVE). These companies are all part of the "transportation" industry. Provexis vs. Its Competitors Norish Alkemy Capital Investments CloudCoCo Group Iconic Labs 22532 (PAA.L) Greka Engineering & Technology Marwyn Management Partners Carnival Co. & Anglo American Savannah Energy Norish (LON:NSH) and Provexis (LON:PXS) are both small-cap transportation companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, profitability, valuation, risk, analyst recommendations, earnings, dividends and institutional ownership. Do institutionals and insiders have more ownership in NSH or PXS? 7.9% of Provexis shares are held by institutional investors. 21.6% of Provexis shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Does the media refer more to NSH or PXS? In the previous week, Norish's average media sentiment score of 0.00 equaled Provexis'average media sentiment score. Company Overall Sentiment Norish Neutral Provexis Neutral Is NSH or PXS more profitable? Norish has a net margin of 0.00% compared to Provexis' net margin of -73.10%. Norish's return on equity of 0.00% beat Provexis' return on equity.Company Net Margins Return on Equity Return on Assets NorishN/A N/A N/A Provexis -73.10%-68.68%-56.14% Which has better valuation and earnings, NSH or PXS? Norish has higher revenue and earnings than Provexis. Provexis is trading at a lower price-to-earnings ratio than Norish, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNorish£36.39M0.00N/A£6.10N/AProvexis£846.98K19.56-£619.15K-£0.03-26.77 SummaryNorish beats Provexis on 6 of the 8 factors compared between the two stocks. Get Provexis News Delivered to You Automatically Sign up to receive the latest news and ratings for PXS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PXS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PXS vs. The Competition Export to ExcelMetricProvexisDrug Manufacturers IndustryMedical SectorLON ExchangeMarket Cap£16.57M£2.23B£5.58B£3.09BDividend Yield5.06%2.92%4.62%5.03%P/E Ratio-26.774.1230.18169.94Price / Sales19.56684.86447.95289,809.14Price / CashN/A10.3737.7527.94Price / Book82.3011.128.425.20Net Income-£619.15K£20.70B£3.26B£5.89B7 Day Performance2.32%2.94%3.70%-0.27%1 Month Performance-9.14%5.88%4.00%0.38%1 Year Performance29.07%4.01%35.79%62.73% Provexis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PXSProvexisN/AGBX 0.71-4.3%N/A+18.7%£16.57M£846.98K-26.774Gap DownNSHNorishN/AN/AN/AN/A£52.62M£36.39M28.691,251Gap UpALKAlkemy Capital InvestmentsN/AGBX 206.13-0.7%N/A+280.0%£18.17MN/A-14.1325,500CLCOCloudCoCo GroupN/AGBX 0.30+6.0%N/A+73.9%£2.18M£27.84M-1.03125Gap DownICONIconic LabsN/AGBX 2.13flatN/A-32.4%£237K£600.86K-6.073PAA22532 (PAA.L)N/AN/AN/AN/A£0.00N/A0.004,100Gap UpHigh Trading VolumeGELGreka Engineering & TechnologyN/AN/AN/AN/A£0.00N/A0.002,110MMPMarwyn Management PartnersN/AN/AN/AN/A£0.00N/A0.001,660CCLCarnival Co. &N/AGBX 1,983.50-0.9%N/A+94.1%£35.84B£32.78B17.9840,000AALAnglo American0.9441 of 5 starsGBX 2,147.90+0.1%GBX 2,156+0.4%-2.5%£32.66B£36.94B-19.78129,700SAVESavannah EnergyN/AGBX 7.20flatN/AN/A£9.45B£18.46B-4.6711,100 Related Companies and Tools Related Companies Norish Alternatives Alkemy Capital Investments Alternatives CloudCoCo Group Alternatives Iconic Labs Alternatives 22532 (PAA.L) Alternatives Greka Engineering & Technology Alternatives Marwyn Management Partners Alternatives Carnival Co. & Alternatives Anglo American Alternatives Savannah Energy Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:PXS) was last updated on 8/14/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredBig Changes Coming in August — Is Your IRA Ready?Banks aren’t waiting for the headlines to catch up. They’ve already started moving their wealth out of pape...Reagan Gold Group | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Provexis plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Provexis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access